date,title,source
Nov-05-18,Implied Volatility Surging for Galectin Therapeutics (GALT) Stock Options,Zacks
Nov-05-18,Data Collected by Exalenz Bioscience in Galectin Therapeutics Phase 2 NASH-CX Trial of GR-MD-02 to Be Presented at AASLD Annual Meeting,GlobeNewswire
